Company page

Nektar Therapeutics

Nektar Therapeutics is a public company traded under the ticker NKTR in the American market, with a market capitalization of approximately $2.39 billion. The company focuses on developing innovative therapies to address unmet medical needs. Nektar is dedicated to advancing its pipeline of drug candidates and improving patient outcomes.